Optimizing Training in Severe Post-Stroke Walking Impairment
NCT ID: NCT04721860
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2020-10-15
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantifying the Role of Sensory Systems Processing in Post-Stroke Walking Recovery
NCT04553198
Gait Training in Post-Stroke Hemiparesis Hemiparesis
NCT04877249
Stroke Rehabilitation Outcomes With Supported Treadmill Ambulation Training
NCT00037895
Falls-based Training for Walking Post-Stroke
NCT02787759
Multimodal Exercise Training Poststroke
NCT03174392
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of this study is to obtain critical pilot data on the effects of extended BLTT on walking speed, symmetry, and balance (static and dynamic), in chronic stroke survivors with baseline severe walking impairment, relative to forward treadmill training controls (FLTT).
Aim 1. Determine the training-related effects of extended BLTT on overground walking speed (primary outcome) in survivors with severe walking impairment. To achieve this aim, we will compare the Pre-Post change in walking speed \[10- meter walk test (10MWT)\] between groups. The working hypothesis is that extended BLTT will increase walking speed to a clinically meaningful level (≥0.16m/s), compared to the control group (FLTT).
Aim 2. Determine the effects of extended BLTT on walking symmetry and balance. The Zeno Walkway Gait Analysis software will capture Pre-Post changes in temporal gait symmetry index during the 10-MWT. Working hypothesis 2a: BLTT will be associated with a favorable improvement in the temporal symmetry index score. Proprioception and spinovestibular function will be measured with the modified Sensorineural Integration Test (mSIT), and dynamic balance will be assessed with the completion time on the instrumented Timed Up \& Go (i- TUG). Working hypothesis 2b and c: BLTT will be associated with a favorable improvement Pre-Post mSIT(a) and completion time on the i-TUG (b).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Backward Locomotion Treadmill Training (BLTT)
Participants train on a reverse treadmill (no bodyweight support), three times per week x 4 weeks.
Backward Locomotion Treadmill Training (BLTT)
12-training sessions of reverse treadmill training (no bodyweight support) over four weeks.
Forward Locomotion Treadmill Training (FLTT)
Participants train on a treadmill (no bodyweight support), three times per week x 4 weeks.
Forward Locomotion Treadmill Training (FLTT)
12-training sessions of forward treadmill training (no bodyweight support) over tfour weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Backward Locomotion Treadmill Training (BLTT)
12-training sessions of reverse treadmill training (no bodyweight support) over four weeks.
Forward Locomotion Treadmill Training (FLTT)
12-training sessions of forward treadmill training (no bodyweight support) over tfour weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Walking speed less than or equal to 0.4 meters/second
* Ability to maintain greater than or equal to 0.3mph speed for 6-minute interval on the treadmill
* Able to walk independently (cane and hemi-walker acceptable)
* Ambulate \>10 meters over ground with the Free Step Harness System (as a safety precaution)
* Discharged from formal rehabilitation
Exclusion Criteria
* Significant language barrier which might prevent the participant from following instructions during training and testing.
* Adverse health condition that might affect walking capacity (severe arthritis, significant pulmonary disease significant ataxia, or severe hemi-neglect)
* Severe lower extremity spasticity (Ashworth \>2)
* Depression (\>10 on the Patient Health Questionnaire, if untreated).
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oluwole Awosika
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cincinnati College of Medicine
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-0784
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.